Key result
Cytoreductive surgery in patients with ovarian cancer resulted in a significantly higher loss of intravascular protein compared to patients with benign ovarian tumors (49 g vs 13 g).
Why the study?
Does cytoreductive surgery for ovarian cancer cause greater intraoperative protein shift compared to surgery for benign ovarian tumours?
Observational (n=28)
Does cytoreductive surgery for ovarian cancer cause greater intraoperative protein shift compared to surgery for benign ovarian tumours?
Patients with ovarian cancer experience significant intraoperative protein shift during cytoreductive surgery, which may explain difficulties in maintaining cardiovascular stability.
Answers are grounded in this paper and cite their sources.
Greater protein loss may underlie hemodynamic instability in ovarian cancer surgery; this cohort study leaves open causal confirmation.
BACKGROUND: [corrected] Clinical experience in patients with ovarian cancer has shown special difficulties in maintaining cardiovascular stability during surgery. METHODS: To evaluate the causes for this observation, 15 patients with benign ovarian tumours (group I) and 13 patients with ovarian cancer (group II) were investigated perioperatively. Plasma volume (indocyanine green-dilution technique), haematocrit, plasma protein concentration, mean arterial pressure, heart rate, and central venous pressure were measured immediately before and after cytoreductive surgery. RESULTS: Normal values of blood-, plasma-, and red cell volume were determined preoperatively in both groups, and in relation to body surface area there were no intergroup differences of these parameters. In group I, the significant decrease in red cell volume of 313 ml postoperatively was compensated for by an increase in plasma volume of 371 ml (median values). In contrast to group I, the decrease in red cell volume of 328 ml in group II was not related to a significant increase in plasma volume, so that blood volume postoperatively was 483 ml lower than preoperatively, although the same standardized infusion regimen as in group I was applied. Patients of group II had a significantly higher loss of intravascular protein (49 g vs 13 g in group I), which left the intravascular space by another way than by surgical bleeding. This extra protein loss is termed Intraoperative Protein Shift (IPS). CONCLUSION: IPS could be an important quantity in perioperative fluid balance. We assume that different surgical procedures predispose to occurrence of differing amounts of IPS.
No takes yet. Share an insight, caveat, or question.
Rehm et al. (1998) conducted an observational in Ovarian cancer and benign ovarian tumours (n=28). Cytoreductive surgery for ovarian cancer vs. Cytoreductive surgery for benign ovarian tumours was evaluated on Loss of intravascular protein. Cytoreductive surgery in patients with ovarian cancer resulted in a significantly higher loss of intravascular protein compared to patients with benign ovarian tumors (49 g vs 13 g).
Synapse has enriched 10 related papers. Consider them for comparative context: